| Short and long‐term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry M Chaparro, A Garre, E Ricart, M Iborra, F Mesonero, I Vera, S Riestra, ... Alimentary pharmacology & therapeutics 48 (8), 839-851, 2018 | 90 | 2018 |
| Tofacitinib in ulcerative colitis: real-world evidence from the ENEIDA registry M Chaparro, A Garre, F Mesonero, C Rodríguez, M Barreiro-de Acosta, ... Journal of Crohn's and Colitis 15 (1), 35-42, 2021 | 75 | 2021 |
| Real‐world short‐term effectiveness of ustekinumab in 305 patients with Crohn’s disease: results from the ENEIDA registry M Iborra, B Beltrán, A Fernández‐Clotet, A Gutiérrez, B Antolín, ... Alimentary pharmacology & therapeutics 50 (3), 278-288, 2019 | 71 | 2019 |
| Effectiveness and safety of ustekinumab in ulcerative colitis: real-world evidence from the ENEIDA registry M Chaparro, A Garre, M Iborra, M Sierra-Ausín, M Barreiro-de Acosta, ... Journal of Crohn's and Colitis 15 (11), 1846-1851, 2021 | 60 | 2021 |
| Real‐world long‐term effectiveness of ustekinumab in Crohn's disease: results from the ENEIDA registry M Iborra, B Beltrán, A Fernández‐Clotet, E Iglesias‐Flores, P Navarro, ... Alimentary Pharmacology & Therapeutics 52 (6), 1017-1030, 2020 | 53 | 2020 |
| Clinical characteristics, associated malignancies and management of primary sclerosing cholangitis in inflammatory bowel disease patients: a multicentre retrospective cohort study I Guerra, L Bujanda, J Castro, O Merino, J Tosca, B Camps, A Gutiérrez, ... Journal of Crohn's and Colitis 13 (12), 1492-1500, 2019 | 49 | 2019 |
| Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry X Andújar, C Loras, B González, M Socarras, V Sanchiz, M Boscà, ... Surgical Endoscopy 34, 1112-1122, 2020 | 30 | 2020 |
| Impact of pain associated with the subcutaneous administration of adalimumab C Gely, L Marín, J Gordillo, M Mañosa, F Bertoletti, F Cañete, ... Gastroenterología y Hepatología 43 (1), 9-13, 2020 | 19 | 2020 |
| Clinical outcome after anti‐tumour necrosis factor therapy discontinuation in 1000 patients with inflammatory bowel disease: the EVODIS long‐term study MJ Casanova, M Chaparro, Ó Nantes, JM Benítez, M Rojas‐Feria, ... Alimentary Pharmacology & Therapeutics 53 (12), 1277-1288, 2021 | 18 | 2021 |
| Effectiveness and safety of ustekinumab in elderly patients with Crohn’s disease: real world evidence from the ENEIDA registry D Casas-Deza, LJ Lamuela-Calvo, F Gomollón, JM Arbonés-Mainar, ... Journal of Crohn's and Colitis 17 (1), 83-91, 2023 | 15 | 2023 |
| Long-term outcomes of biological therapy in Crohn's disease complicated with internal fistulizing disease: BIOSCOPE study from GETECCU M Barreiro-de Acosta, A Fernández-Clotet, F Mesonero, FJ García-Alonso, ... Official journal of the American College of Gastroenterology| ACG 118 (6 …, 2023 | 10 | 2023 |
| Real-World evidence of tofacinitib in ulcerative colitis: short and long-term effectiveness and safety M Chaparro, D Acosta, C Rodríguez, F Mesonero, M Vicuña, ... Official journal of the American College of Gastroenterology| ACG, 10.14309, 2022 | 8 | 2022 |
| Spanish GETECCU group (ENEIDA Project). Clinical characteristics, associated malignancies and management of primary sclerosing cholangitis in inflammatory bowel disease … I Guerra, L Bujanda, J Castro, O Merino, J Tosca, B Camps, A Gutiérrez, ... J Crohns Colitis 13 (12), 1492-1500, 2019 | 8 | 2019 |
| Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease M Calafat, C González-Muñoza, M Fortuny, C Roig, A Calm, A Mombiela, ... Aging Clinical and Experimental Research 33 (8), 2355-2359, 2021 | 7 | 2021 |
| Clinical features, therapeutic requirements and evolution of patients with Crohn’s disease and upper gastrointestinal involvement (CROHNEX study) E Sainz, Y Zabana, I Miguel, A Fernández‐Clotet, B Beltrán, L Núñez, ... Alimentary Pharmacology & Therapeutics 54 (8), 1041-1051, 2021 | 6 | 2021 |
| Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn’s Disease (Versus-CD): Data from the ENEIDA Registry MJ García, M Rivero, A Fernández-Clotet, R de Francisco, B Sicilia, ... Journal of Crohn's and Colitis 18 (1), 65-74, 2024 | 4 | 2024 |
| P262 Effectiveness and safety of ustekinumab in elderly patients: Real world evidence from ENEIDA registry D Casas Deza, LJ Lamuela Calvo, JM Arbonés Mainar, E Ricart, ... Journal of Crohn's and Colitis 15 (Supplement_1), S298-S299, 2021 | 3 | 2021 |
| P434 effectiveness and safety of ustekinumab in ulcerative colitis: Real-world evidence from Eneida Registry M Chaparro, A Garre, M Iborra, M Barreiro-de Acosta, MJ Casanova, ... Journal of Crohn's and Colitis 14 (Supplement_1), S394-S395, 2020 | 3 | 2020 |
| Splanchnic Vein Thrombosis in Inflammatory Bowel Disease: An Observational Study from the ENEIDA Registry and Systematic Review M Puig, H Masnou, F Mesonero, L Menchén, L Bujanda, J Castro, ... Journal of Clinical Medicine 12 (23), 7366, 2023 | 1 | 2023 |
| Percepción de la necesidad de asesoramiento dietético y modificaciones alimentarias en pacientes con enfermedad inflamatoria intestinal C Gely, J Gordillo, F Bertoletti, C González-Muñoza, A López, ... Gastroenterología y Hepatología 46 (5), 329-335, 2023 | 1 | 2023 |
